During the past decade, Centro para el Desarrollo de la Medicina y de Asistencia Médica Especializada, S.C. conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 10 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 6 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centro para el Desarrollo de la Medicina y de Asistencia Médica Especializada, S.C." #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Sunovion" with 3 trials sponsored, "H. Lundbeck A/S" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro para el Desarrollo de la Medicina y de Asistencia Médica Especializada, S.C." #1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "PPD" with 1 trials as a collaborator and "Takeda" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Centro para el Desarrollo de la Medicina y de Asistencia Médica Especializada, S.C." are "Cardiovascular Disease" (2 trials), "Depressive Disorder, Major" (2 trials), "Schizophrenia" (2 trials), "Abiraterone Acetate" (1 trials) and "Androgens" (1 trials). Many other conditions were trialed in "Centro para el Desarrollo de la Medicina y de Asistencia Médica Especializada, S.C." in a lesser frequency.

Most popular intervention types in "Centro para el Desarrollo de la Medicina y de Asistencia Médica Especializada, S.C." are "Drug" (20 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Tirzepatide" (2 trials), "bococizumab (PF-04950615)" (2 trials), "Abemaciclib" (1 trials) and "Abiraterone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro para el Desarrollo de la Medicina y de Asistencia Médica Especializada, S.C." are 19 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Centro para el Desarrollo de la Medicina y de Asistencia Médica Especializada, S.C.". undefined are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Centro para el Desarrollo de la Medicina y de Asistencia Médica Especializada, S.C., undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Centro para el Desarrollo de la Medicina y de Asistencia Médica Especializada, S.C., 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".